Multiple Myeloma
Conditions
Keywords
multiple myeloma
Brief summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. Data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future multiple myeloma patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * Patient has been diagnosed with multiple myeloma * Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion criteria
* Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form * Pregnant, breastfeeding or expecting to conceive within the projected duration of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of participants with multiple myeloma who decide to enroll in clinical trial | 3 Months |
| Rate of patients with multiple myeloma who remain in clinical trial to completion | 12 month |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed